Sign in
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Wet AMD 3 Symposium
2020
Anti-VEGF Injection Prior Authorization Impacts on Retina Practices
Sabin Dang, MD
Updates from the Field
2022
Category: AMD-Neovascular